Lumecca is one of the most powerful intense pulsed light (IPL) devices available today, delivering up to three times more energy than traditional IPL systems in a single session. Developed by InMode, Lumecca uses precisely calibrated broad-spectrum light to target pigmentation irregularities, vascular lesions, and sun damage — restoring clarity, evenness, and radiance to the skin with minimal discomfort and no downtime.
At New York Cornea Consultants & Aesthetics, Lumecca IPL is offered as a highly effective, non-invasive solution for patients looking to address common skin concerns related to sun exposure, aging, and vascular changes. Whether used as a standalone treatment or as part of a comprehensive skin rejuvenation plan, Lumecca delivers visible results that continue to improve in the weeks following each session.
Lumecca emits intense pulses of broad-spectrum light that penetrate the skin and are selectively absorbed by targeted chromophores — the pigmented cells and hemoglobin within blood vessels responsible for brown spots, redness, and vascular irregularities. This selective photothermolysis heats and breaks down the unwanted pigment or vessel without damaging the surrounding healthy tissue.
Following treatment, pigmented lesions typically darken and rise to the surface over the course of several days before naturally flaking off, revealing clearer skin beneath. Vascular lesions such as redness and broken capillaries are absorbed by the body over time, resulting in a more even, uniform skin tone. Because Lumecca delivers significantly more energy per pulse than conventional IPL devices, it achieves results in fewer sessions — making it both more efficient and more effective for patients with moderate to significant skin concerns.
Lumecca IPL is FDA-cleared for a broad range of pigmented and vascular skin concerns, making it one of the most versatile light-based treatments available. Common conditions addressed include:
Lumecca IPL can be safely applied to most areas of the body where sun damage and vascular changes are visible. Commonly treated areas include:
Given our practice's specialized expertise in periocular and facial care, particular attention is given to the safe treatment of the delicate skin around the eyes, with appropriate protective measures used throughout every session.
A Lumecca IPL session begins with a thorough skin assessment and the application of a cool ultrasound gel to the treatment area to enhance comfort and light transmission. Protective eyewear is provided to shield the eyes from the intense light pulses throughout the procedure. The handpiece is applied to the skin in a series of overlapping passes, delivering controlled pulses of light across the entire treatment area.
Most patients describe the sensation as a brief, warm snap — similar to the flick of a rubber band — with each pulse. Treatment time varies depending on the size of the area being addressed, but facial treatments typically take 20 to 30 minutes. No anesthesia or numbing cream is required for most patients, though topical numbing can be applied for those with heightened sensitivity.
Immediately following treatment, mild redness and a warm sensation in the treated area are normal and typically resolve within a few hours. Over the following days, pigmented lesions will darken before naturally shedding, and vascular lesions will gradually fade. Patients are advised to avoid direct sun exposure and apply a broad-spectrum SPF 30 or higher sunscreen consistently throughout the treatment and recovery period.
One of Lumecca's key advantages over conventional IPL systems is the ability to achieve significant results in fewer sessions. Many patients with mild to moderate pigmentation or vascular concerns see meaningful improvement after just one to two treatments. For more extensive sun damage or persistent vascular lesions, a series of three sessions spaced three to four weeks apart is typically recommended to achieve optimal outcomes.
Results continue to develop for four to six weeks following each session as the skin clears treated pigment and absorbs resolved vessels. Patients consistently report a brighter, more even complexion, reduced redness, and an overall refreshed appearance. Annual or biannual maintenance treatments help preserve results and address new sun damage as it develops over time.
Lumecca IPL is most effective for patients with Fitzpatrick skin types I through IV — those with lighter to medium skin tones — as darker skin tones carry a higher risk of post-treatment pigmentation changes due to the increased melanin content in the skin. A thorough consultation and skin type assessment is performed prior to every treatment to ensure candidacy and safety.
Ideal candidates include adults who:
Patients with active skin infections, a history of keloid scarring, or certain autoimmune conditions may not be appropriate candidates, and these factors are reviewed thoroughly during the intake process.
Lumecca IPL pairs exceptionally well with complementary treatments to address multiple skin concerns in a coordinated plan. Common combinations at our practice include:
Your clinician will recommend the most appropriate combination and sequencing of treatments based on your skin type, concerns, and goals.
Lumecca IPL treatments at New York Cornea Consultants & Aesthetics are administered by trained clinical staff under physician oversight. Treatment parameters — including wavelength filters, fluence, and pulse duration — are carefully individualized based on skin type, lesion characteristics, and patient tolerance. Our team's background in ocular and periocular care ensures particular diligence in the safe treatment of the face and the delicate tissue surrounding the eyes.
All patients receive detailed pre- and post-treatment instructions, and our team remains available to address any questions or concerns that arise following a session. We are committed to delivering safe, effective, and evidence-based care at every visit.
To learn more about Lumecca IPL or to schedule a consultation, contact New York Cornea Consultants & Aesthetics today.
